Failure of somatostatin to influence experimental tumor cell growth in vivo and in vitro
✍ Scribed by R. Lenzhofer; C. Cerni; I. Fröhlich; J. Prager; H. Pointner
- Publisher
- Springer
- Year
- 1981
- Tongue
- English
- Weight
- 261 KB
- Volume
- 37
- Category
- Article
- ISSN
- 1420-682X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract We have recently described MAZ51, an indolinone that blocks the ligand‐induced autophosphorylation of VEGFR‐3, a receptor tyrosine kinase that plays a central role in the regulation of lymphangiogenesis. Here we show that MAZ51 is able to block the proliferation of VEGFR‐3‐expressing hu
6500 Mainz, Federal Republic of Germany (G.T., W.M.-K.) Growth-related changes of oxygen consumption rates of tumor cells, grown in vitro or in vivo, were investigated. For in vitro investigations, L929 and DScarcinosarcoma cells were cultured in artificial media. For in vivo studies, DS-carcinosar
Nowadays, some evidences demonstrate that human mesenchymal stem cells (hMSCs) favor tumor growth; however, others show that hMSCs can suppress tumorigenesis and tumor growth. With the indeterminateness of the effect of hMSCs on tumors, we investigated the effect of hMSCs on lung cancer cell line A5